About
Contact & Profiles
A5026233215
Research Areas
- Multiple Sclerosis Research Studies
- Pelvic floor disorders treatments
- Spine and Intervertebral Disc Pathology
- Health Systems, Economic Evaluations, Quality of Life
- Systemic Sclerosis and Related Diseases
- Prostate Cancer Diagnosis and Treatment
- Pelvic and Acetabular Injuries
- Urinary Bladder and Prostate Research
Henry Ford Hospital
2019
Intradetrusor onabotulinum toxin A (BTXA) and sacral neuromodulation (SNM) are effective third-line therapies for overactive bladder (OAB). We aimed to measure the outcomes of BTXA treatment OAB refractory initial SNM identify patient characteristics associated with these outcomes.This retrospective cohort study included patients who failed respond subsequently received at a single provider's clinic between January 2013 December 2016. Treatment successes were defined as willing continue or...
10.5213/inj.1938030.015
article
EN
cc-by-nc
International Neurourology Journal
2019-09-27
Coming Soon ...